Results 181 to 190 of about 70,461 (257)

Managing Nasal Ischemia and Necrosis Post-Triamcinolone Injection: A New Case Series. [PDF]

Case Rep Otolaryngol
Nazari S, Hadadian N, Bayatparidary F, Keyhan SO, Damsaz M, Fakih-Gomez N, Pourani MR.   +6 more
europepmc   +1 more source

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey

British Journal of Clinical Pharmacology, EarlyView.
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink, Iris R. Joosse, Maximilian Salcher‐Konrad, Melanie Walter, Elena Deligianni, Dimitra Tsioumela, Christos Kontogiorgis, Elita Poplavska, Iluta Žīgure, Christina E. Hoeve, Teresa Leonardo Alves, Ella D. van Vliet, Renato Ferreira‐da‐Silva, Ana Kodrič, Mitja Kos, Juan Erviti, Marta Gutiérrez‐Valencia, Luis Carlos Saiz, Sofia Kälvemark Sporrong, Emelie Karlsson, Christine Leopold, Marie L. De Bruin   +21 more
wiley   +1 more source

α-Latrotoxin and Pain: A Nociceptor Perspective on Latrodectism. [PDF]

Toxins (Basel)
Davletov B, Ignatchenko A, Zhantleuova A, Giniatullin RA.   +3 more
europepmc   +1 more source

Cefepime exposure in prolonged or intermittent infusion in critically ill children

British Journal of Clinical Pharmacology, EarlyView.
Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika, Deborah Hirt, Emmanuelle Bille, Sihem Benaboud, Julie Toubiana, Pierre‐Louis Léger, Jérôme Rambaud, Agathe Béranger, Delphine Callot, Sylvain Renolleau, Jean‐Marc Treluyer, Mehdi Oualha, Noémie de Cacqueray   +12 more
wiley   +1 more source

Comment on Honndorf et al. Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. <i>Toxins</i> 2026, <i>18</i>, 142. [PDF]

Toxins (Basel)
Ståhl U, Hamnevik E, Liljegren Sundberg Å, Persson C, Prygova I.   +4 more
europepmc   +1 more source

Dose‐related propofol resistance in COVID‐19 patients: Altered drug plasma levels, mechanistic insights from neuronal‐derived extracellular vesicles and miRNA analysis

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Critical care for COVID‐19 patients presents unique challenges, particularly in sedation management. Patients demonstrate notable dose‐related resistance to propofol, potentially due to complex pharmacokinetic alterations. Emerging evidence suggests that plasma extracellular vesicle‐associated miRNA represents valuable predictive ...
Debora Curci, Carlotta Bidoli, Marco Gerdol, Charisse Winston, Robert A. Rissman, Giuliana Decorti, Antonella Fabretto, Andrea Taddio, Gabriele Stocco, Erik Roman‐Pognuz, Marianna Lucafò   +10 more
wiley   +1 more source

A translational preclinical strategy for chronic spinal cord injury: neuroprotective and regenerative potential of botulinum neurotoxin type A combined with muscle atrophy prevention via electrostimulation. [PDF]

Mil Med Res
Mastrorilli V, Luvisetto S, Ruggieri V, Raparelli G, Madaro L, Paggi LA, Parisi C, De Santa F, De Angelis F, D'Elia A, Massari R, Amadio S, Rossetto O, Vacca V, Caruso M, Sferrazza G, Pavone F, Marinelli S.   +17 more
europepmc   +1 more source

RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 Cleavage. [PDF]

Toxins (Basel)
Batista AF, Singh R, Lee F, Zhuo S, Leonoudakis D, Gallagher CJ.   +5 more
europepmc   +1 more source

Temporal Neuromuscular Adaptations and Proteomic Signatures Following Botulinum Neurotoxin A Injection in Spastic Hemiplegia Rats. [PDF]

CNS Neurosci Ther
Zhong M, Lin H, Yang X, Liu L, Xie Y, Peng T, Luo J, He L, Gao T, Tang H, Xu K.   +10 more
europepmc   +1 more source